Financials
Income statement
Fiscal date | Mar 2025 | Dec 2024 | Sep 2024 | Jun 2024 |
---|---|---|---|---|
Total reported revenue | 20.8B | 22.7B | 20.6B | 20.6B |
Cost of revenue | 18.7B | 15.5B | 18.6B | 18.6B |
Gross profit | 2.1B | 7.2B | 2.0B | 2.1B |
Operating expense | ||||
Research & development | — | — | — | — |
Selling general and admin | — | — | — | — |
Other operating expenses | 1.3B | -458M | 1.4B | 1.3B |
Operating income | 1.4B | 1.5B | 1.3B | 1.4B |
Non operating interest income | ||||
Income | 96M | -65M | 79M | 108M |
Expense | 305M | 148M | 289M | 314M |
Other income expense | — | — | — | — |
Pretax income | 1.2B | 1.6B | 1.2B | 1.2B |
Tax provision | 356M | 459M | 347M | 345M |
Net income | 830M | 1.2B | 811M | 805M |
Basic EPS | 0.7 | — | 0.6 | 0.6 |
Diluted EPS | 0.7 | — | 0.6 | 0.6 |
Basic average shares | 1.2B | — | 1.2B | 1.2B |
Diluted average shares | 1.2B | — | 1.2B | 1.2B |
EBITDA | 2.7B | 3.0B | 2.6B | 2.6B |
Net income from continuing op. | 830M | 1.2B | 811M | 805M |
Minority interests | -43M | -57M | -60M | -61M |
Preferred stock dividends | 0 | 0 | 0 | 0 |